{"id":"https://openalex.org/W2005353760","doi":"https://doi.org/10.4161/cbt.11.11.15527","title":"Comparison of the effects of the PI3K/mTOR inhibitors NVP-BEZ235 and GSK2126458 on tamoxifen-resistant breast cancer cells","display_name":"Comparison of the effects of the PI3K/mTOR inhibitors NVP-BEZ235 and GSK2126458 on tamoxifen-resistant breast cancer cells","publication_year":2011,"publication_date":"2011-06-01","ids":{"openalex":"https://openalex.org/W2005353760","doi":"https://doi.org/10.4161/cbt.11.11.15527","mag":"2005353760","pmid":"https://pubmed.ncbi.nlm.nih.gov/21464613","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3127046"},"language":"en","primary_location":{"id":"doi:10.4161/cbt.11.11.15527","doi":"https://doi.org/10.4161/cbt.11.11.15527","is_oa":true,"landing_page_url":"https://doi.org/10.4161/cbt.11.11.15527","pdf_url":null,"source":{"id":"https://openalex.org/S169029442","display_name":"Cancer Biology & Therapy","issn_l":"1538-4047","issn":["1538-4047","1555-8576"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Biology & Therapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.4161/cbt.11.11.15527","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5036776972","display_name":"Euphemia Yee Leung","orcid":"https://orcid.org/0000-0002-6932-3188","observed_orcids":["https://orcid.org/0000-0002-6932-3188","https://orcid.org/0000-0002-1325-438X"]},"institutions":[{"id":"https://openalex.org/I154130895","display_name":"University of Auckland","ror":"https://ror.org/03b94tp07","country_code":"NZ","type":"education","lineage":["https://openalex.org/I154130895"]}],"countries":["NZ"],"is_corresponding":true,"raw_author_name":"Euphemia Leung","raw_affiliation_strings":["Auckland Cancer Society Research Centre, University of Auckland, Auckland, New Zealand. e.leung@auckland.ac.nz","Auckland Cancer Society Research Centre; University of Auckland; Auckland New Zealand"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Auckland Cancer Society Research Centre, University of Auckland, Auckland, New Zealand. e.leung@auckland.ac.nz","institution_ids":["https://openalex.org/I154130895"]},{"raw_affiliation_string":"Auckland Cancer Society Research Centre; University of Auckland; Auckland New Zealand","institution_ids":["https://openalex.org/I154130895"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100415607","display_name":"Ji Eun Kim","orcid":"https://orcid.org/0000-0002-2156-9875","observed_orcids":["https://orcid.org/0000-0002-2156-9875","https://orcid.org/0000-0002-7856-3255"]},"institutions":[{"id":"https://openalex.org/I154130895","display_name":"University of Auckland","ror":"https://ror.org/03b94tp07","country_code":"NZ","type":"education","lineage":["https://openalex.org/I154130895"]}],"countries":["NZ"],"is_corresponding":false,"raw_author_name":"Ji Eun Kim","raw_affiliation_strings":["UNIVERSITY OF AUCKLAND, Auckland, New Zealand"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UNIVERSITY OF AUCKLAND, Auckland, New Zealand","institution_ids":["https://openalex.org/I154130895"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065865758","display_name":"Gordon W. Rewcastle","orcid":"https://orcid.org/0000-0001-9083-3214","observed_orcids":["https://orcid.org/0000-0001-9083-3214"]},"institutions":[{"id":"https://openalex.org/I154130895","display_name":"University of Auckland","ror":"https://ror.org/03b94tp07","country_code":"NZ","type":"education","lineage":["https://openalex.org/I154130895"]}],"countries":["NZ"],"is_corresponding":false,"raw_author_name":"Gordon W. Rewcastle","raw_affiliation_strings":["UNIVERSITY OF AUCKLAND, Auckland, New Zealand"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UNIVERSITY OF AUCKLAND, Auckland, New Zealand","institution_ids":["https://openalex.org/I154130895"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031189811","display_name":"Graeme J. Finlay","orcid":"https://orcid.org/0000-0001-8853-8187","observed_orcids":["https://orcid.org/0000-0001-8853-8187"]},"institutions":[{"id":"https://openalex.org/I154130895","display_name":"University of Auckland","ror":"https://ror.org/03b94tp07","country_code":"NZ","type":"education","lineage":["https://openalex.org/I154130895"]}],"countries":["NZ"],"is_corresponding":false,"raw_author_name":"Graeme J. Finlay","raw_affiliation_strings":["UNIVERSITY OF AUCKLAND, Auckland, New Zealand"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UNIVERSITY OF AUCKLAND, Auckland, New Zealand","institution_ids":["https://openalex.org/I154130895"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5061684371","display_name":"Bruce C. Baguley","orcid":"https://orcid.org/0000-0001-9943-6987","observed_orcids":["https://orcid.org/0000-0001-9943-6987"]},"institutions":[{"id":"https://openalex.org/I154130895","display_name":"University of Auckland","ror":"https://ror.org/03b94tp07","country_code":"NZ","type":"education","lineage":["https://openalex.org/I154130895"]}],"countries":["NZ"],"is_corresponding":false,"raw_author_name":"Bruce C. Baguley","raw_affiliation_strings":["UNIVERSITY OF AUCKLAND, Auckland, New Zealand"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UNIVERSITY OF AUCKLAND, Auckland, New Zealand","institution_ids":["https://openalex.org/I154130895"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5036776972"],"corresponding_institution_ids":["https://openalex.org/I154130895"],"apc_list":{"value":2710,"currency":"EUR","value_usd":2970},"apc_paid":{"value":2710,"currency":"EUR","value_usd":2970},"fwci":3.8518,"has_fulltext":false,"cited_by_count":79,"citation_normalized_percentile":{"value":0.95118929,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":99},"biblio":{"volume":"11","issue":"11","first_page":"938","last_page":"946"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.00430000014603138,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10756","display_name":"Estrogen and related hormone effects","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1310","display_name":"Endocrinology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tamoxifen-resistance","display_name":"tamoxifen resistance","score":0.9269999861717224},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.7540000081062317},{"id":"https://openalex.org/keywords/pi3k-mtor-inhibitors","display_name":"PI3K/mTOR inhibitors","score":0.9200000166893005},{"id":"https://openalex.org/keywords/nvp-bez235","display_name":"NVP-BEZ235","score":0.9929999709129333},{"id":"https://openalex.org/keywords/gsk2126458","display_name":"GSK2126458","score":0.9900000095367432},{"id":"https://openalex.org/keywords/mcf-7-cells","display_name":"MCF-7 cells","score":0.9010000228881836},{"id":"https://openalex.org/keywords/estrogen-receptor-positive-breast-cancer","display_name":"estrogen receptor-positive breast cancer","score":0.9509999752044678},{"id":"https://openalex.org/keywords/akt-signaling","display_name":"Akt signaling","score":0.9679999947547913},{"id":"https://openalex.org/keywords/p70s6k","display_name":"p70S6K","score":0.9509999752044678},{"id":"https://openalex.org/keywords/ribosomal-protein-s6","display_name":"ribosomal protein S6","score":0.8050000071525574},{"id":"https://openalex.org/keywords/erk-signaling","display_name":"ERK signaling","score":0.8939999938011169},{"id":"https://openalex.org/keywords/cell-cycle-arrest","display_name":"cell cycle arrest","score":0.9330000281333923},{"id":"https://openalex.org/keywords/rapamycin","display_name":"rapamycin","score":0.6470000147819519},{"id":"https://openalex.org/keywords/dual-pi3k-mtor-inhibitor","display_name":"PI3K/mTOR dual inhibitor","score":0.7540000081062317}],"concepts":[{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.8890842199325562},{"id":"https://openalex.org/C75217442","wikidata":"https://www.wikidata.org/wiki/Q423650","display_name":"Protein kinase B","level":3,"score":0.6037563681602478},{"id":"https://openalex.org/C2777176818","wikidata":"https://www.wikidata.org/wiki/Q412178","display_name":"Tamoxifen","level":4,"score":0.5958037972450256},{"id":"https://openalex.org/C57074206","wikidata":"https://www.wikidata.org/wiki/Q14197552","display_name":"MAPK/ERK pathway","level":3,"score":0.5394291877746582},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5114599466323853},{"id":"https://openalex.org/C84606932","wikidata":"https://www.wikidata.org/wiki/Q416496","display_name":"Estrogen receptor","level":4,"score":0.49280837178230286},{"id":"https://openalex.org/C2778504769","wikidata":"https://www.wikidata.org/wiki/Q3040305","display_name":"Aromatase inhibitor","level":5,"score":0.4283856749534607},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4138449430465698},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.4046036899089813},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3839753270149231},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3438454866409302},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3399292826652527},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.33506354689598083},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.296061635017395},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.27889424562454224},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.146916002035141}],"mesh":[{"descriptor_ui":"D000081082","descriptor_name":"Phosphoinositide-3 Kinase Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000096926","descriptor_name":"Benzenesulfonamides","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007093","descriptor_name":"Imidazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D009376","descriptor_name":"Neoplasms, Hormone-Dependent","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D009376","descriptor_name":"Neoplasms, Hormone-Dependent","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D010766","descriptor_name":"Phosphorylation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011065","descriptor_name":"Poly(ADP-ribose) Polymerases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D011724","descriptor_name":"Pyridazines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011804","descriptor_name":"Quinolines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011960","descriptor_name":"Receptors, Estrogen","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D013629","descriptor_name":"Tamoxifen","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D016193","descriptor_name":"G1 Phase","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D018931","descriptor_name":"Antineoplastic Agents, Hormonal","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D038601","descriptor_name":"Ribosomal Protein S6","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D048049","descriptor_name":"Extracellular Signal-Regulated MAP Kinases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D049109","descriptor_name":"Cell Proliferation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D051057","descriptor_name":"Proto-Oncogene Proteins c-akt","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D058570","descriptor_name":"TOR Serine-Threonine Kinases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.4161/cbt.11.11.15527","doi":"https://doi.org/10.4161/cbt.11.11.15527","is_oa":true,"landing_page_url":"https://doi.org/10.4161/cbt.11.11.15527","pdf_url":null,"source":{"id":"https://openalex.org/S169029442","display_name":"Cancer Biology & Therapy","issn_l":"1538-4047","issn":["1538-4047","1555-8576"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Biology & Therapy","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:3127046","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3127046","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Biol Ther","raw_type":"Text"},{"id":"pmid:21464613","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21464613","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer biology & therapy","raw_type":"Comparative Study"},{"id":"pmh:oai:researchspace.auckland.ac.nz:2292/11960","doi":null,"is_oa":false,"landing_page_url":"https://hdl.handle.net/2292/11960","pdf_url":null,"source":{"id":"https://openalex.org/S7407055463","display_name":"ResearchSpace (University of Auckland)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I154130895","host_organization_name":"University of Auckland","host_organization_lineage":["https://openalex.org/I154130895"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.4161/cbt.11.11.15527","doi":"https://doi.org/10.4161/cbt.11.11.15527","is_oa":true,"landing_page_url":"https://doi.org/10.4161/cbt.11.11.15527","pdf_url":null,"source":{"id":"https://openalex.org/S169029442","display_name":"Cancer Biology & Therapy","issn_l":"1538-4047","issn":["1538-4047","1555-8576"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Biology & Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":30,"referenced_works":["https://openalex.org/W1522987052","https://openalex.org/W1588880778","https://openalex.org/W1661647511","https://openalex.org/W1964957120","https://openalex.org/W1966307221","https://openalex.org/W1967913221","https://openalex.org/W1967949926","https://openalex.org/W2000493107","https://openalex.org/W2027542963","https://openalex.org/W2039568738","https://openalex.org/W2039628288","https://openalex.org/W2046410395","https://openalex.org/W2073497404","https://openalex.org/W2078358665","https://openalex.org/W2085908746","https://openalex.org/W2090185686","https://openalex.org/W2102148658","https://openalex.org/W2115950635","https://openalex.org/W2121640179","https://openalex.org/W2126783165","https://openalex.org/W2143695256","https://openalex.org/W2144724291","https://openalex.org/W2145047343","https://openalex.org/W2148848488","https://openalex.org/W2157983986","https://openalex.org/W2158305336","https://openalex.org/W2167383891","https://openalex.org/W2169303908","https://openalex.org/W2171095731","https://openalex.org/W2273740586"],"related_works":["https://openalex.org/W2032200220","https://openalex.org/W2039628288","https://openalex.org/W2025268152","https://openalex.org/W2951148599","https://openalex.org/W3155594866","https://openalex.org/W2097127580","https://openalex.org/W2324285809","https://openalex.org/W2120344853","https://openalex.org/W2039657950","https://openalex.org/W3013073823"],"abstract_inverted_index":{"BACKGROUND:":[0],"Treatment":[1],"with":[2,12,212,230],"anti-estrogens":[3],"or":[4,82],"aromatase":[5],"inhibitors":[6,35,55],"is":[7,32,227],"commonly":[8],"used":[9],"for":[10,69],"patients":[11],"estrogen":[13,84],"receptor-positive":[14],"(ER+)":[15],"breast":[16],"cancers;":[17],"however":[18],"resistant":[19,61],"disease":[20],"develops":[21],"almost":[22],"inevitably,":[23],"requiring":[24],"a":[25],"choice":[26],"of":[27,36,53,56,76,93,101,116,123,135,167,178,187,216],"secondary":[28],"therapy.":[29],"One":[30],"possibility":[31],"to":[33,89,148,156,221,232],"use":[34],"the":[37,49,57,74,77,91,99,111,124,157,188,246],"PI3K/mTOR":[38,58,104],"pathway":[39,59],"and":[40,108,113,127,139,161,191,195,209],"several":[41],"candidate":[42],"drugs":[43,237],"are":[44],"in":[45,50,73,83,172,184,223,244],"development.":[46],"We":[47,65,96],"examined":[48],"vitro":[51],"effects":[52,92,100,204,213],"two":[54,102],"on":[60,110,207],"MCF-7":[62,67,118,225],"cells.":[63],"METHODS:":[64],"cultured":[66],"cells":[68],"prolonged":[70],"periods":[71],"either":[72],"presence":[75],"anti-estrogen":[78],"tamoxifen":[79,149,222],"(3":[80],"sub-lines)":[81,88],"free":[85],"medium":[86],"(2":[87],"mimic":[90],"clinical":[94],"treatment.":[95],"then":[97],"analyzed":[98,131],"dual":[103],"phosphoinositide-3-kinase":[105],"inhibitors,":[106],"NVP-BEZ235":[107,160,194,201,241],"GSK2126458,":[109],"growth":[112],"signaling":[114,199,211],"pathways":[115,129],"these":[117,224],"sub-lines.":[119],"The":[120,142,180],"functional":[121],"status":[122],"PI3K,":[125],"mTOR":[126,247],"ERK":[128,192],"was":[130],"by":[132,165,176],"measuring":[133],"phosphorylation":[134],"AKT,":[136,189],"p70S6K,":[137],"rpS6":[138,210],"ERK.":[140],"RESULTS:":[141],"derived":[143],"sub-lines":[144,226],"showed":[145,202],"increased":[146,154],"resistance":[147,220],"but":[150,200],"none":[151],"exhibited":[152],"concomitantly":[153],"sensitivity":[155],"PI3K":[158,233],"inhibitors.":[159,234],"GSK2126458":[162,196,206],"acted":[163],"mainly":[164],"induction":[166,177],"cell":[168],"cycle":[169],"arrest,":[170],"particularly":[171],"G1-phase,":[173],"rather":[174],"than":[175,205],"apoptosis.":[179],"lines":[181],"varied":[182],"considerably":[183],"their":[185],"utilization":[186],"p70S6K":[190,208],"pathways.":[193],"inhibited":[197,238],"AKT":[198,239],"greater":[203],"resembling":[214],"those":[215],"rapamycin.":[217],"CONCLUSION:":[218],"Increased":[219],"not":[228],"associated":[229],"hypersensitivity":[231],"While":[235],"both":[236],"signaling,":[240],"resembled":[242],"rapamycin":[243],"inhibiting":[245],"pathway.":[248]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":7},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":14},{"year":2013,"cited_by_count":7},{"year":2012,"cited_by_count":13}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}